Participated · Equity · Sep 2025

Inbox Health offers a cloud platform that uses artificial intelligence to generate clear, personalized medical bills and to automate multi-channel payment collection for healthcare providers. Patients can pay via credit card, digital wallet, ACH, phone or check, and can interact with human or AI support agents in 60 languages through calls, chat and email. The system feeds real-time payment posting, analytics and feedback dashboards back to practice staff, aiming to cut administrative workload and reduce unpaid balances. Recent partnerships include an enterprise rollout with CHE Behavioral Health Services and a deepened integration with Greenway Health’s Intergy EHR via the Greenway Marketplace. The company plans to devote new capital to further AI research focused on emotional intelligence and faster issue resolution. Since inception, Inbox Health has raised $55 million in equity financing across multiple rounds to fuel product expansion and market penetration.

Participated · Series A · Sep 2025

Goodpath operates an AI-driven virtual platform that delivers integrated care pathways across weight management, MSK pain, sleep, digestive health, mental health, diabetes, and cancer survivorship. The platform combines AI insights with a multidisciplinary medical team spanning 20+ specialties, unlimited 1:1 coaching, and home-delivered tools to unify care that is typically fragmented. Goodpath's learning care model is fed by more than 4.5 million real-world data points from member assessments, treatments, outcomes, and interactions, which the company says improves personalization and outcome prediction over time. The company reports 15–20% enrollment across eligible populations (and notes enrollment exceeding 20% in some cohorts), roughly five times the industry average, and cites validated studies showing reductions in total medical spend. Goodpath is adopted across Fortune 500 employers, benefits partners, and insurers and emphasizes cost savings for self-insured employers through reduced claims. Planned product investments include outcome prediction models, AI-led personalization tools, expanded prescribing, additional care pathways, and complex care navigation. Goodpath operates a telehealth platform that delivers personalized, integrative care programs for sleep, back pain and Irritable Bowel Syndrome. Its programs are tailored to each patient and can include nutrition and supplements (nutrition coaching and targeted supplements); movement and lifestyle (online yoga and strengthening exercises); mindfulness and meditation (guided meditations and journaling); and one-on-one coaching and guidance. The company was co-founded by CEO Bill Gianoukos, COO & CPO Carl Nehme, and Chief Medical Advisor Dr. Akl Fahed. Goodpath raised $4 million in seed funding to support its growth. The startup intends to use the funds to expand operations and broaden its business reach.

Participated · Series B · Jul 2025

Arbital Health offers an AI-powered platform and a market-leading actuarial team that centralizes fragmented data, automates contract reconciliation, and delivers actuarially driven insights for value-based care. Its product suite includes an Adjudication Module with an Overall Risk Performance Dashboard, plus Performance Monitor and Insights modules that surface KPIs and drivers of risk. The company aims to expand payer- and provider-facing capabilities and grow its actuarial team to accelerate contract performance monitoring, management, and reconciliation across major risk models. Arbital has built a client roster of more than 40 payers, providers, digital point solutions, value-based care enablers, and integrated delivery networks, and has onboarded over 600,000 patient lives to its platform. The company emphasizes reducing administrative burden and increasing transparency to improve engagement, risk scores, and patient outcomes. Arbital was founded in 2024 and operates its team onsite in San Francisco. Arbital Health provides neutral third-party adjudication for outcomes-based contracts across the value-based care landscape, serving payers, providers, life sciences companies, employers, and digital health firms. The company’s initial product offering includes value assessment for point-solution health vendors, value analysis for payers (including employers and health plans), and actuarial advisory services. Arbital expanded its actuarial and consulting capabilities through the acquisition of Santa Barbara Actuaries, Inc., which specializes in value-based contracting, predictive modeling, and data analytics. The acquisition enables Arbital to offer a dedicated value-based care actuarial team and access to SBA’s clients. Arbital is co-founded by Travis May and Brian Overstreet. The company recently completed a $10M Series A financing to support growth and product rollout.

Participated · Equity · Oct 2024

Cornerstone AI develops AI software to clean, prepare, and analyze real-world healthcare data, automating identification and correction of inconsistencies and filling missing data. Its solution learns dataset structures and relationships, creates models for each data point, and exports clean data with a complete audit trail. The company says its tools streamline healthcare data management to improve efficiency and accuracy for biopharma and healthcare customers. Cornerstone is based in San Francisco and was founded in 2019. Leadership is shifting as Viraj Narayanan will become CEO while founder Michael Elashoff transitions to Chief Science Officer to focus on AI algorithm development. With the new capital the company plans to enhance its data processing solutions. Cornerstone AI builds automated software that structures and corrects healthcare data to accelerate data analysis and medical research. Its platform uses self-learning AI methods and includes a regulatory-grade audit trail. The product enables teams to use more patients and more data points for more precise analyses. Cornerstone is already working with companies across multiple medical areas, data sources and volumes, and customers have reported outstanding results. Led by CEO Michael Elashoff, the company plans to use new funding to further product development and scale the business to meet demand. The company is based in San Francisco, CA.

Led · Seed · Oct 2023

LighthouseAI provides a centralized platform that combines software and a team of state licensing experts to manage pharmaceutical licensing and compliance across every U.S. state and jurisdiction. Its customers include manufacturers, wholesale distributors, third-party logistics providers, 503A and 503B facilities, pharmacies, repackagers, reverse distributors, virtual manufacturers, and healthcare providers. The company launched Rapid Assessments, a product that analyzes more than 100 facility attributes and produces a guaranteed set of regulatory requirements across 55 U.S. jurisdictions instantly. LighthouseAI serves 250 customers and processed 2025 change-of-ownership transactions representing more than $12 billion in combined revenue. The company reached initial profitability in Q4 2025, employs 85 people, and has recently expanded its commercial leadership with the appointment of a Chief Commercial Officer. Series A proceeds are intended to fund delivery improvements, further product development, and expanded services to support growth.